Ann Arbor, Mich. – May 10, 2018 – TRAZER today announced that it has been selected to present at the 37th annual Michigan Growth Capital Symposium (MGCS). The company, with its proprietary technology objectively quantifies Human health and performance, will present to investors in attendance, which represent more than 100 top venture capital firms. More than 400 entrepreneurs, researchers, investment professionals and business executives are expected to attend the Symposium, which will be held May 15-16 at the Marriott Resort in Ypsilanti, Mich.
First held in 1981, MGCS is the premier, must-attend event for venture capitalists, technology transfer professionals, founders, CEOs and the best of the Midwest early stage and emerging, high-growth companies that are seeking institutional investment. The two-day conference will feature a keynote address from Wendell Brooks, senior VP of Intel Corporation and president of Intel Capital, as well as engaging industry panel discussions and networking opportunities for attendees.
“TRAZER assesses movement,” says Barry French, CEO, “whether it’s healthy or injured. Its ability to measure how well the brain and body work together make it ideal for concussion management, for performance training, to detect overtraining syndrome, for physical therapy and for balance training and testing. We are very excited for the opportunity to present, at MGCS, TRAZER to such an incredibly talented and knowledgeable group of individuals and companies.”
“For nearly four decades, the Symposium has played an essential role in connecting the best and the brightest Midwest entrepreneurs with the investors they need to access new sources of funding to bring their businesses to the next level,” said David Brophy, Michigan Growth Capital Symposium founder and director of the University of Michigan’s Center for Venture Capital & Private Equity. “Once again, I am impressed by the caliber of companies that will be presenting at this year’s event, and we are glad to have TRAZER join the ranks.”
To learn more, see the full list of presenting companies or register for the conference, visit www.michigan-gcs.com and follow conversations about the Symposium by tracking #MichiganGCS on Twitter. For more information about TRAZER, please visit www.trazer.com.
TRAZER is the world-wide leader in the use of computer simulation for the assessment and enhancement of health and physical/cognitive performance. With the use of simulation and high-powered optics, TRAZER’s patented technology places a patient/athlete in a virtual environment which uniquely replicates real world conditions and simultaneously quantifies previously unmeasurable data pertinent to an individual’s health. TRAZER provides instant, objective, actionable data to the clinician, athletic trainer, patient and insurance company, providing invaluable information regarding the athlete rehabbing from an ACL, an athlete returning-to-play from a concussion, or the best performer.
About the Michigan Growth Capital Symposium
The Michigan Growth Capital Symposium (MGCS) is the original university-based venture investment fair, which was first held in 1981. This decades-old nationally attended event is the largest Midwest fair of its kind that brings together venture capital investors, business angels, start-up companies, university tech transfer officers and research faculty. MGCS provides an opportunity for participants from the venture capital community to connect with Midwest start-ups seeking funding and to learn about emerging innovations that span tech and the life sciences. MGCS is presented by the Center for Venture Capital & Private Equity Finance and the Zell Lurie Institute at the University of Michigan Ross School of Business, with support from the Michigan Venture Capital Association.